Primary hyperoxaluria type 3 (PHT3) is a rare inherited disorder characterized by excess production of oxalate in the body, which leads to its accumulation and formation of kidney stones, as well as damage to the renal tissue. This disease is caused by a deficiency of the enzyme 4-hydroxyphenylpyruvate dehydrogenase (HLD) in the liver, which leads to impaired metabolism of glyoxylate and, as a result, hyperoxaluria. Primary hyperoxaluria type 3 can manifest itself throughout the patient's life, and its course is influenced by various factors. It is important to note that the clinical picture of this disease can vary from asymptomatic to severe complications, including renal failure.
History of the disease and interesting historical facts
Primary hyperoxaluria was first described in medicine in the early 20th century. The first information about hyperoxaluria was associated with observations of patients who had kidney stones containing calcium oxalate. In the 1990s, thanks to advances in molecular genetics, it was established that PGT-3 is caused by mutations in the HLD gene, which made it possible to more accurately diagnose the disease and conduct its genetic testing. Interestingly, in the process of studying different types of primary hyperoxaluria, a full spectrum of mutations was identified, which indicated the diversity of clinical manifestations of this disorder. For a long time, hyperoxaluria was considered one of the rare diseases, but with the increase in available diagnostic methods, it became possible to identify a larger number of cases of the disease.
Epidemiology
The epidemiology of primary hyperoxaluria type 3 shows that this disease is very rare in the population, with an approximate frequency of 1 in 100,000 people. Available data indicate a higher prevalence of this disease in certain ethnic groups, which is associated with inheritance features and mutations in the HLD gene. As a result of collecting statistics, it became obvious that PGT-3 is most often diagnosed in patients aged 20 to 50 years, but the initial symptoms can manifest already in childhood. It is important to consider that due to limited information and insufficient awareness of the disease, cases of primary hyperoxaluria may remain undiagnosed or misdiagnosed for a long time.
Genetic predisposition to this disease
Primary hyperoxaluria type 3 is caused by mutations in the HLD gene located on chromosome 10. The next stage of research revealed significant polymorphism of this gene, indicating the presence of various mutations leading to dysfunction of the 4-hydroxyphenylpyruvate dehydrogenase enzyme. The main types of mutations include point mutations, deletions and insertions. The phenotypic expression of the disease may vary depending on the type of mutation. Since PGT-3 is inherited in an autosomal recessive manner, the risk of transmitting a genetic predisposition is estimated at 25% for each subsequent child in the family if there are mutation carriers. Genetic testing is an important tool for diagnosis and risk counseling for future generations.
Risk factors for the development of this disease
Risk factors that contribute to the development of primary hyperoxaluria type 3 include:
- Heredity. The presence of cases of the disease in the family significantly increases the risk of the disease in children.
- Ethnic origin: Some ethnic groups, such as Ashkenazi Jews, have a higher predisposition to mutations in the HLD gene.
- Age. The disease most often manifests itself in late childhood or young adulthood.
- Diet: An unhealthy diet rich in oxalates may worsen the condition in susceptible patients.
It is also worth considering that environmental factors, such as exposure to certain chemicals, may have an indirect effect on the development of the disease.
Diagnosis of this disease
Diagnosis of primary hyperoxaluria type 3 includes several key steps:
- Main symptoms: Clinical manifestations may include pain in the kidney area, the presence of oxalate stones in the urine, and renal failure.
- Laboratory tests: Urine analysis for oxalate and calcium, as well as a biochemical blood test to determine kidney function.
- Radiological examinations. Ultrasound examination of abdominal organs and kidneys, computed tomography to assess the size and location of stones.
- Other diagnostics: Genetic testing to detect mutations in the HLD gene, which helps confirm the diagnosis.
- Differential diagnosis: Other causes of hyperoxaluria should be excluded, including secondary forms such as chronic kidney disease or metabolic disorders.
Treatment
Treatment of primary hyperoxaluria type 3 should begin with conservative measures:
- General recommendations: Change your diet to reduce oxalate intake, increase fluid intake to dilute urine.
- Pharmacological treatment. Use of drugs such as pyridoxine (vitamin B6), which can reduce oxalate levels.
- Surgical treatment: In severe cases, when large stones form or kidney failure occurs, surgery or even a kidney transplant may be required.
- Other treatments: If necessary, dialysis for patients with end-stage renal failure.
List of drugs used to treat this disease
Medications for the treatment of primary hyperoxaluria type 3 include:
- Pyridoxine (vitamin B6)
- Calcium citrate to reduce oxalate absorption
- Anti-inflammatory drugs in the presence of renal colic
Disease monitoring
Patient monitoring includes regular examinations to assess kidney function and urinary oxalate levels:
- Control stages. Regular blood and urine tests, ultrasound of the kidneys.
- Prognosis: Early diagnosis and treatment can significantly improve the patient's prognosis, although the risk of complications remains.
- Complications: Possible complications include chronic kidney failure requiring dialysis or kidney transplant.
Age-related features of the disease
Primary hyperoxaluria type 3 can manifest itself throughout the patient's life:
- Childhood: Symptoms may be unobservable or mild, making diagnosis difficult.
- Adolescence and young adulthood: The likelihood of developing symptoms and complications increases, especially with water loss and high oxalate intake.
- Adulthood. The risk of developing kidney failure increases, as does the possibility of forming a large number of stones.
Questions and Answers
- What are the main symptoms of primary hyperoxaluria type 3? The main symptoms include renal colic, the presence of oxalate stones in the urine and signs of renal failure.
- How is this disease diagnosed? Diagnosis is based on clinical symptoms, laboratory tests, radiological examinations and genetic testing.
- Can primary hyperoxaluria be prevented? Prevention includes genetic counseling for families with a history of the disease and dietary changes, but the disease itself cannot be prevented.
- What is the treatment for this disease? Treatment may include dietary changes, drug therapy, surgery in severe cases, and dialysis if needed.
- What is the outlook for patients with primary hyperoxaluria type 3? With adequate treatment and monitoring, the condition may remain stable, but there is a risk of developing complications that require surgical correction.
